NASDAQ:XRAY - DENTSPLY SIRONA Stock Price, News, & Analysis

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

DENTSPLY SIRONA announced a quarterly dividend on Tuesday, June 26th. Stockholders of record on Friday, September 28th will be given a dividend of $0.0875 per share on Friday, October 12th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date of this dividend is Thursday, September 27th. View DENTSPLY SIRONA's Dividend History.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) issued its quarterly earnings data on Tuesday, August, 7th. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.01. The medical instruments supplier earned $1.04 billion during the quarter, compared to analyst estimates of $1.03 billion. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. During the same quarter in the previous year, the firm posted $0.65 earnings per share. View DENTSPLY SIRONA's Earnings History.

DENTSPLY SIRONA is scheduled to release their next quarterly earnings announcement on Friday, November, 2nd 2018. View Earnings Estimates for DENTSPLY SIRONA.

DENTSPLY SIRONA issued an update on its FY18 earnings guidance on Tuesday, August, 7th. The company provided earnings per share (EPS) guidance of $2.00-2.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.57. The company issued revenue guidance of $3.9 billion, compared to the consensus revenue estimate of $4.17 billion.

13 equities research analysts have issued 1 year price targets for DENTSPLY SIRONA's stock. Their predictions range from $38.00 to $75.00. On average, they expect DENTSPLY SIRONA's stock price to reach $52.1818 in the next year. This suggests a possible upside of 33.9% from the stock's current price. View Analyst Price Targets for DENTSPLY SIRONA.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for DENTSPLY SIRONA.

DENTSPLY SIRONA saw a increase in short interest in July. As of July 31st, there was short interest totalling 9,481,193 shares, an increase of 29.0% from the July 13th total of 7,349,832 shares. Based on an average trading volume of 2,208,648 shares, the short-interest ratio is presently 4.3 days. Currently, 4.2% of the company's stock are short sold. View DENTSPLY SIRONA's Current Options Chain.

Some companies that are related to DENTSPLY SIRONA include Straumann (SAUHF), Sartorius (SARTF), Nobel Biocare (NBHGF), BIOLASE (BIOL), Biomerica (BMRA) and Remedent (REMI).

Media stories about XRAY stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. DENTSPLY SIRONA earned a media and rumor sentiment score of 0.12 on Accern's scale. They also assigned press coverage about the medical instruments supplier an impact score of 47.35 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View Recent Headlines for DENTSPLY SIRONA.

DENTSPLY SIRONA's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.20%), Veritas Asset Management LLP (4.44%), Massachusetts Financial Services Co. MA (2.30%), Bank of America Corp DE (1.40%), Orbimed Advisors LLC (1.08%) and Macquarie Group Ltd. (1.06%). Company insiders that own DENTSPLY SIRONA stock include Arthur D Kowaloff, Bret W Wise, Christopher T Clark, Donald M Jr Casey, Eric Brandt, Francis J Lunger, James G Mosch, Mark Thierer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman, Nicholas W Alexos, Rainer Berthan and Ulrich Michel. View Institutional Ownership Trends for DENTSPLY SIRONA.

XRAY stock was sold by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Millennium Management LLC, Putnam Investments LLC, Victory Capital Management Inc., SG Americas Securities LLC, Select Equity Group L.P., FMR LLC and Nomura Holdings Inc.. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Francis J Lunger, Michael C Alfano and Michael J Coleman. View Insider Buying and Selling for DENTSPLY SIRONA.

XRAY stock was purchased by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Veritas Asset Management LLP, Nuance Investments LLC, Thompson Siegel & Walmsley LLC, Bank of America Corp DE, Mawer Investment Management Ltd., Douglas Lane & Associates LLC and Anchor Capital Advisors LLC. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Donald M Jr Casey, Mark Thierer and Nicholas W Alexos. View Insider Buying and Selling for DENTSPLY SIRONA.

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of XRAY stock can currently be purchased for approximately $38.97.

DENTSPLY SIRONA has a market capitalization of $8.60 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,550,000,000.00 in net income (profit) each year or $2.66 on an earnings per share basis. DENTSPLY SIRONA employs 16,100 workers across the globe.

DENTSPLY SIRONA's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected]